Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 7Gynecologic 4Thoracic 2Sarcoma 1NET 1Genitourinary 1Endocrine 1Breast 1

Conditions

Neuroendocrine Tumors 28Neoplasms 4Melanoma 4Carcinoma, Neuroendocrine 4Sarcoma 3Pheochromocytoma 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Liver Neoplasms 3Gastro-enteropancreatic neuroendocrine tumor 3Colonic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma 3Carcinoid Tumor 3Breast Neoplasms 3Thyroid Neoplasms 2Thymus Neoplasms 2Stomach Neoplasms 2Salivary Gland Neoplasms 2Rectal Neoplasms 2Prostatic Neoplasms 2Paraganglioma 2Neoplasms by Site 2Neoplasms by Histologic Type 2Neoplasm Metastasis 2Multiple Myeloma 2Meningioma 2Lung Neoplasms 2Insulinoma 2Head and Neck Neoplasms 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Appendiceal Neoplasms × NET × 30 days × Clear all
NCT06263088 2026-05-22

EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.

Case Comprehensive Cancer Center

Phase NA Recruiting
200 enrolled
EndocrineGastrointestinalNET

Anus Neoplasms, Appendiceal Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡